Analyst Price Target is $47.75
▲ +16.98% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Apollo Medical in the last 3 months. The average price target is $47.75, with a high forecast of $55.00 and a low forecast of $41.00. The average price target represents a 16.98% upside from the last price of $40.82.
Current Consensus is
Moderate Buy
The current consensus among 4 contributing investment analysts is to moderate buy stock in Apollo Medical. This Moderate Buy consensus rating has held steady for over two years.
Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare company, provides medical care services in the United States. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. The company was incorporated in 1985 and is headquartered in Alhambra, California.
Read More
